Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cybin Inc (NEO: CYBN)

 
CYBN Technical Analysis
5
As on 9th Jun 2023 CYBN SHARE Price closed @ 0.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.95 & Strong Sell for SHORT-TERM with Stoploss of 1.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CYBNSHARE Price

Open 0.33 Change Price %
High 0.33 1 Day -0.02 -6.25
Low 0.30 1 Week -0.06 -16.67
Close 0.30 1 Month -0.10 -25.00
Volume 87151 1 Year -1.20 -80.00
52 Week High 1.60 | 52 Week Low 0.31
 
NEO Canada Most Active Stocks
CCHW 0.65 -4.41%
CCHW 0.65 -4.41%
GRAM-U 0.32 6.67%
FH 0.08 0.00%
MEDI 0.01 -50.00%
CYBN 0.30 -6.25%
ETHC 1.60 -4.19%
SLVE 14.89 0.27%
MMED 4.93 -2.76%
ABXX 8.43 -0.24%
 
NEO Canada Top Gainers Stocks
MYCO 0.26 8.33%
GRAM-U 0.32 6.67%
RIGP-UN 18.11 2.20%
GLDE 17.14 1.72%
NBND 17.28 0.99%
FGX 2.86 0.35%
FGX 2.86 0.35%
CERE-U 9.95 0.30%
SLVE 14.89 0.27%
PUB-UN 13.17 0.23%
 
NEO Canada Top Losers Stocks
MEDI 0.01 -50.00%
MEDI 0.01 -50.00%
CYBN 0.30 -6.25%
CYBN 0.30 -6.25%
CCHW 0.65 -4.41%
CCHW 0.65 -4.41%
ETHC 1.60 -4.19%
MMED 4.93 -2.76%
FCS-UN 2.99 -0.33%
ABXX 8.43 -0.24%
 
 
CYBN
Daily Charts		 CYBN
Intraday Charts		 Whats New @
Bazaartrend		 CYBN
Free Analysis
 
CYBN Important Levels Intraday
RESISTANCE0.36
RESISTANCE0.34
RESISTANCE0.33
RESISTANCE0.32
SUPPORT0.28
SUPPORT0.27
SUPPORT0.26
SUPPORT0.24
 
CYBN Forecast April 2024
Share
4th UP Forecast1.03
3rd UP Forecast0.8
2nd UP Forecast0.65
1st UP Forecast0.51
1st DOWN Forecast0.09
2nd DOWN Forecast-0.05
3rd DOWN Forecast-0.2
4th DOWN Forecast-0.43
 
CYBN Weekly Forecast
4th UP Forecast0.99
3rd UP Forecast0.77
2nd UP Forecast0.63
1st UP Forecast0.50
1st DOWN Forecast0.10
2nd DOWN Forecast-0.03
3rd DOWN Forecast-0.17
4th DOWN Forecast-0.39
 
CYBN Forecast2024
4th UP Forecast2.88
3rd UP Forecast2.05
2nd UP Forecast1.54
1st UP Forecast1.03
1st DOWN Forecast-0.43
2nd DOWN Forecast-0.94
3rd DOWN Forecast-1.45
4th DOWN Forecast-2.28
 
 
CYBN Other Details
Segment EQ
Market Capital 380611200.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CYBN Address
CYBN
 
CYBN Latest News
 
Your Comments and Response on Cybin Inc
 
CYBN Business Profile
Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada. Address: 100 King Street West, Toronto, ON, Canada, M5X 1C9
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service